Evidence map›Paper›PMID 35185820›Full record

ArticleFrontiers in microbiology2021

Antimicrobial Resistance Dynamics in Chilean

Cecilia S Toro, Juan Carlos Salazar, David A Montero, Juan Antonio Ugalde, Janepsy Díaz, Leandro A Cádiz, Tania Henríquez, Camila García, Patricia Díaz, Rossanna Camponovo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Cecilia S ToroPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Juan Carlos SalazarPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
David A MonteroPrograma Disciplinario de Inmunología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Juan Antonio UgaldeC+, Research Center in Technologies for Society, School of Engineering, Universidad del Desarrollo, Santiago, Chile.
Janepsy DíazDepartamento de Estudios Científicos, Instituto de Salud Pública de Chile, Santiago, Chile.
Leandro A CádizPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Tania HenríquezPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Camila GarcíaEscuela de Tecnología Médica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Patricia DíazPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
Rossanna CamponovoIntegramédica-BUPA, Santiago, Chile.
Germán HermosillaPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
María Teresa UlloaPrograma de Microbiología y Micología, Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile.
University of Chile · CLInstituto de Salud Pública de Chile · CLMillennium Initiative for Collaborative Research on Bacterial Resistance · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shigellosis is an enteric infectious disease in which antibiotic treatment is effective, shortening the duration of symptoms and reducing the excretion of the pathogen into the environment.

Indexed as

antibiotic resistanceclass 2 integrondfrA14integronsmobile genetic elements (MGE)multidrug-resistant (MDR) bacteriaShigella sonneiSRL pathogenicity island

Identifiers

PMID35185820
PMCPMC8854971
OpenAlexW4210776052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.